Fermenta Biotech Submits FY26 Annual Report and AGM Notice
Fermenta Biotech Ltd has submitted its Annual Report for the financial year 2025-26, along with the notice for its 74th Annual General Meeting (AGM). The AGM is scheduled for Tuesday, August 11, 2026, at 3:00 p.m. IST. The report highlights the company's operating momentum, strategic conviction, and capital commitment, emphasizing its role in providing high-standard, science-backed nutritional ingredients. Fermenta leverages its expertise in process, molecular science, and green chemistry to serve global customers across pharmaceutical, dietary supplement, food and beverage, and animal nutrition sectors. The report details the company's innovation in APIs, intermediates, and environmental solutions, supported by global manufacturing and R&D capabilities. It also touches upon strategic alliances, international certifications, and a strong focus on research and development.
Key Highlights
- Annual Report for FY25-26 submitted, detailing company performance.
- 74th AGM scheduled for August 11, 2026, at 3:00 p.m. IST.
- Focus on operating momentum and strategic conviction for growth.
- Emphasis on innovation in nutritional ingredients and green chemistry.
- Global reach with over 400 customers in more than 60 countries.
Price Impact
More from FERMENTA